Walter Petersohn - 25 May 2021 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
Chief Commercial Officer
Signature
Dane Baumgardner, Attorney-In-Fact for Walter Petersohn
Issuer symbol
XRAY
Transactions as of
25 May 2021
Net transactions value
-$548,683
Form type
4
Filing time
26 May 2021, 16:42:56 UTC
Next filing
13 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Options Exercise $272,160 +7,937 +17% $34.29 55,222 25 May 2021 Direct
transaction XRAY Common Stock Sale $534,874 -7,937 -14% $67.39 47,285 25 May 2021 Direct F1
transaction XRAY Common Stock Options Exercise $353,523 +9,488 +20% $37.26 56,773 25 May 2021 Direct
transaction XRAY Common Stock Sale $639,491 -9,488 -17% $67.40 47,285 25 May 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Stock Option (Right to Buy) Options Exercise $0 -7,937 -100% $0.000000* 0 25 May 2021 Common Stock 7,937 $34.29 Direct F3
transaction XRAY Stock Option (Right to Buy) Options Exercise $0 -9,488 -100% $0.000000* 0 25 May 2021 Common Stock 9,488 $37.26 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.38 to $67.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.40 to $67.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 This option is fully vested and exercisable.